19 Apr 2024
Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23
Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23
15 Apr 2024
Updates to the HTA Policy and Methods Review Reference Committee – 15 April 2024
Updates to the HTA Policy and Methods Review Reference Committee – 15 April 2024
05 Apr 2024
PBAC Public Summary Documents – December 2023 meeting
PBAC Public Summary Documents – December 2023 meeting
03 Apr 2024
National Health (Pharmaceutical Benefits) Regulations 2017 amendments
National Health (Pharmaceutical Benefits) Regulations 2017 amendments
03 Apr 2024
Agenda for the July 2024 PBAC meeting – 3 April 2024
Agenda for the July 2024 PBAC meeting – 3 April 2024
02 Apr 2024
Public Consultation: Draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
Consultation on the draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme (PBS) and designated vaccines on the National Immunisation Program (NIP) is now open.
01 Apr 2024
1 April 2024 designated brand list – minimum stockholding requirements
1 April 2024 designated brand list – minimum stockholding requirements